Objective-Abdominal aortic aneurysm is an inflammatory disease leading to destructive vascular remodeling and ultimately to lethal aortic rupture. Despite its frequent association with atherosclerosis, compelling studies have shown striking differences and potentially opposite roles of T-cell helper responses in aneurysm as compared with atherosclerosis, casting doubt on the relevance and suitability of T-cell-targeted therapies in this context. Approach and Results-Here, we show that selective depletion of T regulatory (Treg) cells using a CD25-specific monoclonal antibody significantly enhances the susceptibility of C57Bl/6 mice to angiotensin II-induced abdominal aortic aneurysm and promotes aortic rupture (n=25-44 mice/group). Similar results are observed in angiotensin II-treated Cd80 −/− /Cd86 −/− or Cd28 −/− mice with impaired Treg cell homeostasis (n=18-23 mice/group). Treg cell depletion is associated with increased immune cell activation and a blunted interleukin (IL)-10 anti-inflammatory response, suggesting an immunoinflammatory imbalance. Interestingly, Il-10 −/− mice (n=20 mice/group) show increased susceptibility to angiotensin II-induced abdominal aortic aneurysm and aortic rupture and are insensitive to Treg cell depletion. Finally, reconstitution of Cd28 −/− Treg-deficient mice with Treg cells (n=22 mice/group) restores a balance in the immunoinflammatory response, rescues the animals from increased susceptibility to aneurysm, and prevents aortic dissection. Conclusions-These results identify a critical role for Treg cells and IL-10 in the control of aneurysm formation and its progression to rupture and suggest that therapies targeting Treg responses may be most suited to treat aneurysmal disease. (Arterioscler Thromb Vasc Biol. 2013;33:2374-2379.)
A bdominal aortic aneurysm (AAA) carries important morbidity and mortality, particularly in men and women aged >60 years. 1 Despite recent advances in the understanding of its pathophysiological mechanisms, therapeutic options in AAA are still limited. 2 There is no evidence that medical therapy approved for the prevention and treatment of coronary heart disease would be appropriate for the prevention or treatment of AAA. 2, 3 In most cases, the development of AAA in humans occurs concomitantly with the development and progression of atherosclerosis. However, recent studies could not find direct causal relationship between atherosclerosis and AAA. 4, 5 Inflammatory mechanisms are involved in the development and progression of both atherosclerosis and AAA. Intriguingly, however, mechanistic studies in animal models of atherosclerosis and AAA indicate that the 2 processes may be controlled by different and potentially opposing patterns of immune responses, particularly T cell-mediated responses. Total B and T lymphocyte deficiency in recombination activating gene-1 (Rag-1) −/− mice reduces atherosclerosis under moderate hypercholesterolemia. However, it does not significantly alter AAA development. 6 A bias toward T helper (Th)1dependent immunity is observed in human and experimental atherosclerosis, 7 whereas AAA lesions are mostly Th2 biased, 8, 9 although some studies reported Th1 bias. 10, 11 Direct inhibition of Th1 responses reduces the development of experimental atherosclerosis but accelerates AAA formation and complications, 12 suggesting that targeting Th1 responses in atherosclerosis might be associated with significant undesirable effects on AAA progression. Thus, a better understanding of the role of T cell immune responses in AAA is required to develop efficient and safe therapeutic strategies.
We hypothesized that beyond alterations of a specific Th cell subset, an upstream defect in the regulatory arm of the immune response, previously shown to promote atherosclerosis, 13 might set the stage for increased susceptibility to AAA. Interestingly, recent studies reported associations between reduced percentages of circulating immunoregulatory T-cell subsets, namely CD31 + T cells and CD4 + CD25 + Foxp3 + T regulatory (Treg) cells, and the development of AAA in humans, 14, 15 suggesting that impaired Treg cell function might contribute to the pathogenesis of AAA. Here, we provide direct experimental evidence that Treg cells control the development of AAA in mice, suggesting novel therapeutic options for this severe disease.
Materials and Methods
Materials and Methods are available in the online-only supplement.
Results

CD25 Antibody-Mediated Treg Cell Depletion Promotes the Development of Angiotensin II-Induced AAA in C57Bl/6 Mice
To address the role of Treg cells in aortic aneurysm formation, we used a variant of the angiotensin II (AngII)-induced AAA model 16 and subjected C57Bl/6 mice to AngII infusion for 28 days (see Methods in the online-only Data Supplement). As previously reported, normocholesterolemic C57Bl/6 mice show reduced susceptibility to AngII-induced AAA compared with Apoe −/− mice. 16, 17 Interestingly, however, Treg cell depletion using anti-CD25 monoclonal antibody ( Figure 1A ) led to important T-cell activation ( Figure 1B) , significantly increased the incidence and severity of aneurysm, and predisposed to fatal aortic rupture ( Figure 1C and 1D). Enhanced susceptibility to AAA in Treg-depleted mice was associated with increased vascular accumulation of T cells ( Figure 1E ) and marked elastin degradation ( Figure 1F ).
Loss of Treg Cells in Cd80 −/− /Cd86 −/− Mice Promotes the Development of AAA
We then reasoned that genetic depletion of Treg cells might also predispose animals to AAA formation. Foxp3 deletion in mice is generally associated with rapid onset of severe autoimmune manifestations 18, 19 making it unsuitable for AAA experiments. We, therefore, used Cd80 −/− /Cd86 −/− (also called B7 −/− ) or Cd28 −/− mice, in which T-cell homeostasis Figure 1 . T regulatory (Treg) cell depletion increases abdominal aortic aneurysm (AAA) incidence and severity. A, Efficiency of Treg cell (CD4 + CD25 high Foxp3 + ) depletion in spleen and blood (gated on CD4 + T lymphocytes) of C57BL/6 mice infused with angiotensin II (AngII) during 4 weeks and treated with anti-CD25 or a control antibody at days 0 and 14 after osmotic pump implantation. B, Increase of CD4 + T-cell activation in Treg-depleted mice with an increase of CD69 and CD44 high expression by spleen CD4 + T cells. Data are representative of 6 mice per group and confirmed in a separate experiment. C, A significant increase of AAA incidence and severity (stage 0, no aneurysm to stage 4, ruptured aneurysm) in Treg-depleted mice. D, Survival curves (free from AAA rupture) in the same groups of mice infused with AngII. E and F, Representative photomicrographs of aortas recovered from mice infused with AngII and stained for the presence of T lymphocytes (CD3, E) and elastin (Orcein, F; n=8/group). *P<0.05; **P<0.01; and ***P<0.001. Scale bar: E and F, 200 μm.
is preserved under basal conditions, despite a marked loss of Treg cells, most probably because of a balance between Treg cell loss and disruption of B7 (Cd80/86)/Cd28 costimulatory effector T-cell pathway. 20, 21 Treg cell deficiency in Cd80 −/− /Cd86 −/− and Cd28 −/− mice has previously been shown to exacerbate autoimmune-mediated diseases under defined experimental conditions. 20, 21 Interestingly, AngII infusion into Cd80 −/− /Cd86 −/− mice led to a significant increase of aneurysm incidence, severity, and occurrence of fatal aortic rupture ( Figure 2 ). 
Loss of Treg Cells Is Associated With a Blunted Interleukin-10 Anti-Inflammatory Response and Increased Th1 Immune Cell Activation
Having established that genetic or antibody-induced Treg deficiency promotes AAA formation and rupture, we wanted to address the underlying mechanisms. We found that Treg-deficient Cd28 −/− mice displayed increased AAA development already at day 7 after AngII infusion ( Figure 3A) , indicating an early acceleration of the disease in the absence of Treg cells. Enhanced susceptibility to AAA in Cd28 −/− mice was associated with increased vascular accumulation of leukocytes ( Figure I in the onlineonly Data Supplement), particularly T cells ( Figure 3B) , and an imbalance of the systemic (spleen, Figure 3C ) and local (aortic, Figure 3D ) immunoinflammatory response as reflected by low interleukin (IL)-10 but high expression of IL-12 and interferon-γ. Interestingly, coculture of Treg but not T effector cells with macrophages greatly promoted IL-10 but limited IL-12 production ( Figure II in the online-only Data Supplement), further suggesting a role for this anti-inflammatory pathway in Treg protective effects.
Il-10 −/− Mice Show Increased Susceptibility to AngII-Induced AAA and Aortic Rupture
To address the hypothesis that the inflammatory imbalance associated with Treg cell depletion might have contributed to increased AAA, we subjected Il-10 −/− mice to AngII infusion and found increased aneurysm incidence and severity compared with wild-type controls ( Figures 4A and 4B ). Again, this was associated with a marked elastin degradation ( Figure 4C ) and substantial accumulation of T cells within the aneurysmal lesions ( Figure 4D ). Treg levels were similar between Il-10 −/− mice and controls ( Figure III in the online-only Data Supplement). Interestingly, however, Treg cell depletion did not aggravate the disease in Il-10 −/− animals ( Figures 4A and 4B) , indicating an IL-10-dependent mechanism for the protective role of Treg cells against AAA development. Figure 5A ), which was associated with a substantial reduction of T cell activation ( Figure 5B ) and proliferation ( Figure 5C ), an increase Figure 5D ), and a blunted interferon-γ production ( Figure 5E ), clearly suggesting a limitation of immune-mediated responses. The apparent discrepancy between the modest increase in Treg cell percentage in vivo and the marked effect on the regulation of the immune response can be explained by the fact that the transferred Treg cells expressed CD28, which unlike recipient Treg and T effector cells, makes them responsive to B7 costimulation and clearly endows them with better functional properties. Interestingly, Treg supplementation abrogated the susceptibility of Cd28 −/− mice to AAA ( Figure 5F and 5G) , which was associated with a prevention of vascular T-cell infiltration ( Figure 5H ) and a preservation of elastin content ( Figure 5I ).
Supplementation of Cd28 −/− Mice With Treg Cells Limits the Development of AAA
Discussion
This is the first study to directly address the role of Treg cells in AAA. We clearly show that genetic or antibody-mediated depletion of Tregs promotes activation of T-cell immunity and leads to accelerated development and severity of AAA in response to AngII. A previous study reported a role for T cells in AngII-induced hypertension. 22 However, we found no difference in blood pressure response to AngII infusion between Treg-deficient and wild-type mice ( Figure V in the online-only Data Supplement). Instead, enhanced susceptibility to AAA was associated with impaired balance of the immunoinflammatory response and reduced IL-10 production, which was corrected by resupplementation with natural activated Tregs. We also show for the first time that IL-10 expression substantially limits aneurysm development and severity. Interestingly, Treg cells do not protect against AAA in IL-10-deficient animals. Collectively, the results establish a critical role for Treg-IL-10 pathway in the protection against AngII-induced AAA.
There are several potential limitations to this study. Only 1 model of AAA was used. We preferred the AngII-induced AAA model to other invasive models (local elastase or chemically induced aortic injury) to limit procedure-related inflammatory responses that might interfere with Treg effects. Another limitation is that AAA development in this model often starts with medial aortic dissection, which might not fully reproduce the mechanisms of AAA development in humans. 23 Future studies should be carefully designed to assess the relevance of our findings to other forms of inflammation-driven AAA. In addition, we used Apoe +/+ rather than Apoe −/− mice to avoid interference with the atherosclerotic process, given the atheroprotective properties of Treg cells. 13 Confirmation of our findings in an atherosclerotic model might be valuable because most patients with AAA also have atherosclerosis. Finally, we did not test the effect of Treg cells on the expansion of already established AAA.
In conclusion, we have identified an important role for Treg cells and IL-10 in limiting vascular inflammation, dilatation, and rupture in an AngII-induced experimental model of aneurysm formation in mice. The results, together with recent observations in humans suggesting reduced Treg cell function in patients with AAA, 14,15 support a prominent role for Treg cell function in limiting the development and progression of AAA. We believe that therapies targeting Treg cell and IL-10 pathways should be considered for the treatment of aneurysms with inflammatory component. 
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